PI Industries Limited has submitted to the Exchange, the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended June 30, 2025.
PIIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PI Industries reported Q1 FY26 standalone revenue from operations of ₹17,691 Mn, down about 12% from ₹20,120 Mn in Q1 FY25, while sequentially rising 7% from Q4 FY25. Standalone profit after tax fell nearly 7% YoY to ₹4,643 Mn (from ₹4,984 Mn), but grew about 20% from Q4 FY25's ₹3,858 Mn. On a consolidated basis, revenue was ₹19,005 Mn (vs ₹20,689 Mn YoY) and PAT was ₹4,000 Mn (vs ₹4,488 Mn YoY). The Agrochemicals segment continues to dominate, but its revenue declined YoY, while the Pharma segment revenue nearly tripled to ₹723 Mn though it still posted a ₹760 Mn loss. Price Waterhouse issued an unmodified (clean) limited review report with no qualifications or emphasis of matter.
Mixed picture for shareholders: YoY revenue and profit declined due to soft agrochemical demand, but the sequential recovery and continued strong margins suggest stabilization. The Pharma segment is scaling up but is still loss-making, so near-term focus stays on agrochemical recovery before any re-rating.